Robot-assisted segmental resection of tubal pregnancy followed by end-to-end reanastomosis for preserving tubal patency and fertility: An initial report by 諛뺤＜�쁽 et al.
Observational Study Medicine®
OPENRobot-assisted segmental resection of tubal
pregnancy followed by end-to-end reanastomosis
for preserving tubal patency and fertility
An initial report
Joo Hyun Park, MDa,c, SiHyun Cho, MDa,c, Young Sik Choi, MDb,c, Seok Kyo Seo, MDb,c,
Byung Seok Lee, MD, PhDb,c,
∗
Abstract
The objective of this study was to evaluate whether robotic tubal reanastomosis after segmental resection of tubal pregnancy is a
feasible means of preserving tubal integrity and natural fertility in those with compromised contralateral tubal condition.
The study was performed at a university medical center in a retrospective manner where da Vinci robotic system-guided segmental
resection of tubal ectopic mass followed by reanastomosis was performed to salvage tubal patency and fertility in those with a single
viable fallopian tube. Of the 17 patients with tubal pregnancies that were selected, 14 patients with successful tubal segmental
resection and reanastomosis were followed up. The reproducibility of anastomosis success and cumulative pregnancy rates of up to
24 months were analyzed.
Patient mean age was 28.88±4.74 years, mean amenorrheic period was 7.01±1.57 weeks and mean human chorionic
gonadotropin (hCG) level was 9289.00±7510.00mIU/mL. The overall intraoperative cancellation rate due to unfavorable positioning
or size of the tubal mass was 17.65% (3/17), which was converted to either salpingectomy or milking of ectopic mass. Of the 14
attempted, anastomosis for all 14 cases was successful, with 1 anastomotic leakage. One patient wishing to postpone pregnancy
and 2 patients where patency of the contralateral tube was conﬁrmed during the operation, were excluded from the pregnancy
outcome analysis. Cumulative pregnancy rate was 63.64% (7/11), with 3 (27.27%) ongoing pregnancies, 3 (27.27%) livebirths, and 1
missed abortion at 24 months. During the follow-up, hysterosalpingography (HSG) was performed at 6 months for those who
consented, and all 10 fallopian tubes tested were patent. No subsequent tubal pregnancies occurred in the reananstomosed tube for
up to a period 24 months.
For patients with absent or defective contralateral tubal function, da Vinci-guided reanastomosis after segmental resection of tubal
pregnancy is feasible for salvaging tubal patency and fertility.
Abbreviations: ART = assisted reproductive technique, hCG = human chorionic gonadotropin, HSG = hysterosalpingography,
IVF = in vitro fertilization, MTX = methotrexate.
Keywords: ectopic pregnancy, fertility-preserving surgery, robotic surgery, tubal factor infertility, tubal pregnancy, tubal
reanastomosis, tubal segmental resection1. Introduction
Ectopic pregnancy, the most common site being the fallopian
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1women and accounts for 4% to 10% of pregnancy-related
deaths.[1–3] Unless spontaneous regression occurs, most tubal
pregnancies without intervention, will rupture into the abdomi-
nal cavity creating various degrees of hemoperitoneum. The
occurrence of tubal pregnancy in one tube predisposes to a 6–7-
fold risk of developing another contralateral tubal pregnancy
since both fallopian tubes share similar risk factors including
inﬂammation and adhesion.[3,4] For women who have unequiv-
ocal contralateral tubal function or received a previous
salpingectomy, an additional salpingectomy predisposes to
complete tubal factor infertility. Nevertheless, the most frequent
form of surgery for tubal pregnancy is salpingectomy, where the
procedure itself leads to permanent loss of fallopian tube
structure and function.
Complete removal of the ectopically implanted embryo is
usually achieved with the resection of the whole fallopian tube
even when the remaining tubal segments are viable. Conventional
options including methotrexate (MTX) therapy, salpingotomy,
and milking of the ectopic implant can be considered for
preserving the integrity of the affected fallopian tube. However,
only a proportion of ectopic pregnancies are diagnosed early and
are candidates for such conservative management.[5] Tubal
Park et al. Medicine (2016) 95:41 Medicinepregnancies are more commonly discovered when symptoms
become prominent due to rupture or hemoperitoneum, narrow-
ing the window of opportunity for a successful MTX therapy.[6,7]
Frequently, tubal pregnancies are accompanied by irreversible
damage to the affected tubal segment due to trophoblastic
invasion. As most implants are highly vascularized, sole
evacuation of the conceptus becomes risky due to bleeding
and a subsequent salpingectomy will frequently be chosen. Also,
the concern over the added risk of suffering another tubal
pregnancy in the salpingotomized fallopian tube has limited its
popularity.[8,9] When tubal factor infertility occurs as a result of
losing both fallopian tube integrity, in vitro fertilization (IVF) is
also an option for conceiving. However, preserving the possibility
of natural pregnancy is nevertheless important depending on the
patient’s individual circumstances and regarding cost-effective-
ness.
Tubal reanastomosis using the da Vinci system has been
reported for patients who wish to recover fertility after tubal
ligation[10–15] and also with conventional laparoscopy.[16–19]
Robotically guided segmental resection of tubal pregnancy and
end-to-end reanastomosis have not been previously elaborated.
The da Vinci robotic system provides optimal microsurgical tubal
reanastomosis conditions for this purpose, where the improved
ergonomics provide a higher degree of freedom for suture
placement and tissue handling.
Taking full advantage of the da Vinci robotic system, we
propose performing segmental resection tubal pregnancy and
subsequent end-to-end reanastomosis of the remaining segments
as a means of salvaging natural fertility in women with a single
viable fallopian tube. Cases where tubal pregnancy has occurred
in those with absent or occluded contralateral fallopian tube
were primarily recruited. The success rates, reproducibility of
techniques, and pregnancy rates with a follow-up of up to
24 months were analyzed.2. Methods
2.1. Patient selection
In this retrospective study, a total of 17 segmental resections of
tubal pregnancy followed by end-to-end reanastomosis were
attempted using the da Vinci robotic system (Intuitive Surgical,
Mountain View, CA) for tubal pregnancy from Aug 2012 to
April 2014 at the Department of Obstetrics and Gynecology,
Gangnam Severance Hospital, Yonsei University College of
Medicine, Seoul, Korea. The study was approved by the
institutional review board (Gangnam Severance Hospital). All
surgeries were performed by a team with the same supervising
faculty experienced with gynecologic laparoscopy as well as
robotic surgery with the daVinci system. The supervising surgeon
also had expertise in mini-laparotomy-microscopy-guided and
laparoscopy-guided tubal reanastomosis following tubal ligation.
Collected data were retrospectively analyzed for up to a period of
24 months. A total of 14 patients were actually eligible for the
reanastomosis since intraoperative ﬁndings rendered 3 patients
inappropriate for the procedure and were converted to
salpingectomies. Informed consent was obtained from all patients
after providing a detailed description of the operative process and
possible associated complications. The possibility of suffering
another tubal pregnancy after the anastomosis was also
informed. Primary indication for recruitment was those with a
previous contralateral salpingectomy as a result of previous tubal
pregnancy or isolated hydrosalpinx in which an additional2salpingectomy would result in complete tubal factor infertility.
Patients with complete obstruction of the contralateral tube as a
result of previousMTX therapy for contralateral tubal pregnancy
were also recruited for the reanastomosis procedure. As patients
who have received contralateral salpingectomy as a part of
surgery for endometriosis or other benign ovarian tumors would
have confounding factors for subsequent pregnancy rates, these
patients were not enrolled for the analysis. Patients with both
fallopian tubes with risk factors for tubal dysfunction wishing to
preserve the affected tube were also recruited but were excluded
from the pregnancy outcome analysis. Other options for future
trial of pregnancy were also explained, including salpingectomy
followed by assisted reproductive techniques. The diagnosis of
tubal pregnancy was established through symptoms, menstrual
history, pelvic ultrasonography ﬁndings, and adjunctive serum
human chorionic gonadotropin (hCG) levels. Patient enrollment
was decided based on the following criteria: those diagnosed with
tubal pregnancy actively seeking to conceive afterwards with
stable vital signs, ages under 40 years, those with spontaneous or
post-MTX rupture, presence of fetal heartbeat, and serum hCG
levels initially over 5000 mIU/mL or elevated hCG levels despite
MTX therapy. Exclusion criteria were unstable vital signs
including increased pulse rate and hypotension, intractable pain,
hemoperitoneum greater than 500mL, ectopic implants greater
than 5cm, preoperative serum hCG levels of less than 1500mIU/
mL without rupture where MTX therapy would be the primary
choice, as well as those with hCG level decrease of more than
50% after 48hours. Pregnancies within close proximity to or
within the cornual area were also excluded as well as those
occupying the ﬁmbria. Information including detailed obstetrical
and gynecological history with reference to medical records was
obtained.2.2. Positioning of the robotic system
The patients were placed in dorsal lithotomy and Trendelenburg
position under general anesthesia. A Kronner uterine manipu-
lator was inserted. A 12-mm trocar was placed at the umbilicus
for a 30° camera insertion. An 8-mm trocar was placed for the
1st robotic arm, 8cm left lateral and 2cm caudal, and another 8-
mm trocar for the 2nd robotic arm 8cm right lateral and 2cm
caudal to the umbilical camera port. A transparent 5-mm
accessory port was placed in the left lower quadrant at the level
of left anterior superior iliac spine, making sure there is minimal
collision with the robotic arms when accessory tools are used
(Fig. 1). The robot was docked in a conventional manner
between the patient legs. Irrigation, suction, introduction, and
removal of suture materials as well as indwelling of silastic
drainage at completion were carried out through the accessory
port. The ﬁrst assistant stood at the patient’s left and the second
assistant on the patient’s right side.
2.3. The operative procedure
After appropriately placing the robotic tools into the abdomi-
nal cavity, complete suction, irrigation, and removal of any
blood clots were performed. Using the Precise or fenestrated
bipolar forceps, the fallopian tube was manipulated by
grasping the serosa to delineate the portion which needs to
be resected. Any adhesions were lysed and the broad ligament
was mobilized to prevent distortion of the remaining tubal
segments. Adequate bleeding control of the ectopic mass was
established in prior, but a clean cut was eventually placed just
Figure 1. Port placement for the tubal reanastomosis procedure. A 12-mm
camera is inserted at the umbilicus (A); 8-mm port for robotic arm 1, utilizing
either monopolar scissors or a wristed needle driver (B); 8-mm port for robotic
arm 2, typically using bipolar forceps (C), when the surgeon has right dexterity;
a 5-mm transparent accessory port is placed in the left lower quadrant (D) for
the 1st assistant to manipulate.
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electrical injury to the tubal ﬂaps. Bleeding from the
mesosalpinx was controlled with limited, focal use of bipolar
energy. Chromopertubation was performed before the anasto-
mosis using diluted indigo carmine solution (5mL in 100mL of
0.9% NaCl solution) to check for patency of the proximal
tubal segment (Fig. 2). To prevent thrombosis, diluted heparin
solution (5000U in 1000mL of 0.9% NaCl solution) was
dripped on the resected tubal surface during anastomosis.
Using the bipolar forceps as a grasper via the ﬁrst robotic arm
and the MegaSuture Cut (Intuitive Surgical, Mountain View,
CA) forceps via the 2nd robotic arm, interrupted sutures were
placed. The mesosalpinx was approximated using #6–0 Vicryls
with interrupted sutures. With the direction of the mesosalpinx
designated as 6 o’clock, the tubal epithelium was approximated
with #7–0 Vicryls at the 12, 3, 6, and 9 o’clock sites with
interrupted sutures. The sutures were left untied until sutures in
all 4 directions were properly placed and were sequentially tied.
The muscularis layer was then approximated with 4 interrupted
sutures using #7–0 Vicryls. Then the serosa around the
anastomosed area was approximated with interrupted sutures
using #6–0 Vicryls (Fig. 3). To check for patency as well as any
leakage at the anastomosis site, chromopertubation with indigo
carmine solution was performed via the uterine cannula
(Fig. 3). The abdominal cavity was thoroughly irrigated and
an antiadhesive ﬁlm was deposited on the anastomosed
fallopian tube to prevent adhesion as well as shearing. A
closed silastic drain was placed through the accessory port
puncture site to check for postoperative bleeding. Parameters
for successful immediate operative outcomes were measured
and recorded.32.4. Postoperative follow-up
Prognostic parameters including intrauterine pregnancy rates,
ongoing pregnancies, live births, miscarriages, and subsequent
ectopic pregnancies were recorded. Routine postoperative
follow-ups were performed at 1 week, 6 months, 12 months,
and 24 months, with exception for those who have already
conceived. Routine blood workup and stitch out was performed
at 1 week. During the follow-up period, hysterosalpingography
(HSG) was performed at 6 months for those who have consented
and pregnancy outcomes were monitored and analyzed at 12
months and 24 months postoperatively. GraphPad Prism
software (La Jolla, CA) was used to test for normality and to
evaluate mean, standard deviation, and conﬁdence intervals or
range.3. Results
Of the 14 patients, 12 patients had previous history of tubal
surgery or suspected tubal occlusion, 10 with contralateral
salpingectomy and 2 with complete obstruction of the contralat-
eral tube as a result of previous MTX therapy, conﬁrmed during
the surgery. The mean age of patients was 28.88±4.75 (range
19–37) years and mean body mass index was 21.01±1.28
(range 19.41–24.22) kg/m2. Mean gravidity and parity were
1.94±0.99 and 0.06±0.25, respectively. The mean period of
amenorrhea at the time of surgery was7.01±1.57 (range
3.71–10.29) weeks and mean preoperative serum hCG level
was 9289.00±7510.00 (range 1007.00–26353.00) mIU/mL.
Time relapsed from diagnosis to the commencement of surgery
on average was 28.31±19.11 (range 4.65–70.20) hours. Two of
the 14 (14.29%) patients had ruptured fallopian tubes afterMTX
therapy and surgical management was decided due to severe pain
(Table 1).
3.1. Intraoperative and immediate postoperative ﬁndings
Mean total surgery time was 194.60±31.28 (range
102.00–235.00) minutes, with mean 7.38±1.63 (range
5.00–10.00) minutes docking time and 147.2±32.54 (range
48.00–186.00) minutes console time. Mean tubal mass size was
3.47±1.33 (range1.60–5.50) cm. The mean volume of hemo-
peritoneum estimated at the beginning of surgery was 281.30±
228.70mL. The most common site of implantation was the
ampulla (78.57%, 11/14), followed by the isthmic portion
(21.43%, 3/14). Mean preoperative hemoglobin level was
12.43±1.41g/dL and postoperative hemoglobin level was
10.08±1.76g/dL. After the reanastomosis, successful passage
of indigo carmine dye via the ﬁmbrial end was observed in all
14 cases. However, in one ampullary pregnancy where there
was considerable discrepancy between the proximal and distal
tubal segments, focal leakage of dye was observed at the
anastomosis site. Mean residual tubal length after reanasto-
mosis was 6.05±0.75 (range 5.00–7.50) cm. From the 17
cases, initially attempted 14 (82.35%) cases were actually
appropriate for reanastomosis and thus 3 were excluded from
the ﬁnal analysis. Two isthmic pregnancies too close to the
cornual area and 1 pregnancy overlying the ﬁmbrial end were
considered inappropriate for the procedure. Either salpingec-
tomy or milking was inevitably performed, showing an
intraoperative cancellation rate of 17.65%. Postoperative
transfusion was required in 2 of the 14 (14.29%) patients
who received the anastomosis. Mean hospitalization time was
3.50±0.82 days (Table 2).
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Figure 2. Procedure for a bulky tubal ectopic mass. A 31-year-old nulliparous woman with a previous history of MTX therapy due to right tubal pregnancy and
intraoperatively obstruction of the previously affected fallopian tube was conﬁrmed. The condition was diagnosed at 7.43 weeks of amenorrhea and the ectopic
mass at the left ampulla was 4.3cm in size, partially ruptured with initial hemoperitoneum of 200mL. (A) The tubal implant is inspected to decide to what extent the
fallopian tube including the ectopicmass causing permanent damage needs to be resected. Any surrounding adhesions are lysed. (B) Since extra trimming could be
performed for the damaged tube later on, initially, the ectopic mass is resected conserving as much tubal segment as possible. (C) Resection of the antimesenteric
portion with minimal usage of energy device. (D) Once the tubal implant is completely resected, chromopertubation is performed to check for proximal patency. (E)
Healthy tubal epithelium is identiﬁed and approximated at 12, 3, 6, 9 o’clock with #7–0 Vicryls, placing sutures ﬁrst and tying them sequentially at the end. (F) The
muscularis is approximated also with #7–0 Vicryl. (G) The serosal layer is approximated with #6–0 Vicryls. (H) After the anastomosis is complete, chromopertubation
is performed to check for patency as well as leakage at the anastomosis site. (I) Hysterosalpingography after 6 months.
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During the 24-month follow-up, pregnancy outcome was
monitored for 11 patients in whom pregnancy would occur
only through the reanastomosed fallopian tube. Three of 14
patients with successful reanastomosis were not included in the
pregnancy outcome analysis for several reasons. Two patients
who chose reanastomosis were conﬁrmed to have patent
contralateral tubes during surgery, thus would yield inconclusive
results as to which fallopian tube had contributed to the4pregnancy. One patient who inserted a levonorgestrel intrauter-
ine device due to changes in family planning was also excluded.
Of the 11 patients, there were 7 (63.64%) intrauterine
pregnancies and 1 case of missed abortion. There were 3
(27.27%) ongoing pregnancies and 3 (27.27%) live births up to a
24-month follow-up. No tubal pregnancy occurred at the
reananstomosed fallopian tube, but 1 (9.09%) patient that
was not included in the pregnancy rate analysis had tubal
pregnancy in the contralateral tube, which seemed patent at the
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Figure 3. Stepwise description of standard operative procedure for resection of tubal ectopic mass followed by reanastomosis. A 35-year-old nulliparous woman
with unruptured left tubal pregnancy, preoperative serum human chorionic gonadotropin (hCG) of 26,353mIU/mL with presence of fetal heartbeat within the
gestational sac and a history of right salpingectomy 10 years ago. (A) The proximal end is resected with monopolar scissors, using minimal energy source. The
tissue is mainly handled by grasping the serosa covering the fallopian tube segment that is to be resected. (B) The distal end is also resected in the samemanner. (C)
The mesosalpinx is anchored using #6–0 Vicryls. (C) Interrupted sutures with #7–0 Vicryls are placed to approximate the fallopian tube epithelium. (D) The sutures
for tubal epithelium are placed at 12, 3, 6, 9 o’clock directions and sequentially tied intracorporeally after all 4 sutures are completely placed. (E) Themuscularis layer
is approximated with #7–0 Vicryls. (F, G) The serosa is approximated with #6–0 Vicryls and any defects in the mesosalpinx are repaired.
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Table 1
Patient characteristics.
Parameters Value
Age, y (mean±SD) 28.88±4.75
BMI, kg/m2 (mean±SD) 21.01±1.28
Gravidity (mean±SD) 1.94±0.99
Parity (mean±SD) 0.06±0.25
Amenorrhea, wk (mean±SD) 7.01±1.57
Preoperative hCG level, mIU/mL (mean±SD) 9289.00±7510.00
Preoperative hemoglobin level, g/dL (mean±SD) 12.43±1.41
Ultrasonographic presence of fetal heartbeat, % (n/N) 21.43 (3/14)
Tubal risk factor
Presence of conﬁrmed/suspected tubal
risk factor, % (n/N)
85.71 (12/14)
Previous contralateral salpingectomy, % (n/N) 71.43 (10/14)
History of conservative treatment for pregnancy
of contralateral tube, % (n/N)
14.29 (2/14)
Current MTX therapy before surgery, % (n/N) 14.29 (2/14)
Time lag from decision to surgery, h (mean±SD) 28.31±19.11
Kolmogorov–Smirnov test performed as normality test before obtaining mean values.
BMI=body mass index, hCG=human chorionic gonadotropin, MTX=methotrexate, SD= standard
deviation.
Table 3
Postoperative success parameters including cumulative preg-
nancy outcome.
Parameters Rate
Tubal patency by hysterosalpingography
(6 months), % (n/N)
100.00 (10/10)
∗
Pregnancy outcome (24 months)
Intrauterine pregnancy, % (n/N) 63.64 (7/11)†
Ongoing pregnancy, % (n/N) 27.27 (3/11)
Spontaneous abortion, % (n/N) 9.09 (1/11)
Live birth, % (n/N) 27.27 (3/11)
Ectopic pregnancy, % (n/N) 0 (0/11)
∗
Total number = not yet pregnant at 6 months that consented.
† Total number = from 14 patients who have completed the reanastomosis those wishing to postpone
pregnancy/contralateral tubal patency were excluded.
Park et al. Medicine (2016) 95:41 Medicinetime of surgery. At 6-month follow-up, HSG was performed for
those with successful reanastomosis and not yet pregnant, and of
the 10 anastomosed salpinges checked, all were patent (Table 3).4. Discussion
Applying novel technique and technology is an important asset of
gynecologic surgery with no exception for tubal reanastomosis.
Conventionally, microsurgical tubal reanastomosis has been
performed with a mini-laparotomy using an intraoperative
microscope unit or laparoscopy for those who have received
sterilization by means of bilateral tubal ligation, and have been
described in detail by different groups.[16–22] Despite the
numerous merits of minimally invasive surgery, laparoscopy-
guided microsurgery has not gained as much popularity as otherTable 2
Intraoperative parameters for tubal reanastomosis after segmen-
tal resection of tubal pregnancy.
Parameters Value
Tubal implant site
Ampulla, % (n/N) 78.57 (11/14)
Isthmus, % (n/N) 21.43 (3/14)
Ectopic mass size, cm (mean±SD) 3.47±1.33
Ruptured ectopic mass, % (n/N) 85.71 (12/14)
Anastomosis success
Completion of anastomosis on attempt, % (n/N) 100.00 (14/14)
Leakage at anastomosis site, % (n/N) 7.14 (1/14)
Residual tubal length, cm (mean±SD) 6.05±0.75
Operation time
Total operating time, min (mean±SD) 194.60±31.28
Docking time, min (mean±SD) 7.38±1.63
Console time, min (mean±SD) 147.20±32.54
Immediate postoperative hemoglobin
concentration, g/dL (mean±SD)
10.08±1.76
Transfusion rate, % (n/N) 14.29 (2/14)
Admission days, d (mean±SD) 3.50±0.82
Kolmogorov–Smirnov test performed as normality test performed before obtaining mean values.
SD= standard deviation.
6gynecologic procedures due to limitations with conventional
instrumentation, magniﬁcation, and its nonergonomic nature.
After the introduction of robotic surgery, tubal reanastomosis
has been described by several authors as a novel means of
restoring tubal patency for those who have received tubal
ligation.[10–15] The da Vinci robotic surgical unit is well suited for
this purpose for several reasons. First of all, a combined
optical–digital magniﬁcation of up to 15-fold is available with a
more abstract binocular vision. A better view of the tubal lumen is
available without any additional microscopic devices and the
usage of ﬁner suture materials and surgical techniques is possible
using the robotic system. The articulated nature of the robotic
arms allows a greater degree of freedom when multiple sutures
are placed in various directions. Physiologic hand tremor, which
is a major hindrance in microsurgery, is attenuated by the robotic
system, facilitating the suturing process with consistency. Also,
the surgeon sits at the console for the robotic procedure and
fatigue is minimized. However, robotic surgery in most systems is
2 to 5-fold higher in cost. The set-up process including patient
positioning and docking is more complex and tool exchange has
to be performed by the assistant, with the surgeon out of the
operative ﬁeld.[14–15]
When tubal pregnancy is diagnosed, themost common practice
is a salpingectomy. Debate continues over whether conservative
therapy for the affected tube improves pregnancy outcome when
the contralateral tube is healthy.[9,23–25] When the only existing
tube is affected, however, preserving tubal integrity should be
seriously considered. The history of the patient, ipsilateral
adhesions, and contralateral tubal function are known factors
that affect subsequent fertility and should be individualized as to
which management is appropriate.[8] When both salpinges are
sacriﬁced as a result of bilateral salpingectomies, tubal factor
infertility could be overcome by assisted reproductive technique
(ART) including IVF.[26,27] Yet, having ART as the only option is
a burden for many couples wishing to conceive with regards to
cost and may cause dilemma for those not yet with a life partner.
When MTX therapy is ineffective, other conservative surgeries
including salpingotomy and milking have been described.
However, these conservative methods were reported to increase
the odds of having another tubal pregnancy and cannot be
performed when tubal damage is signiﬁcant.[9,28] With respect
to future tubal function, complete removal of the affected tubal
portion has the beneﬁt of not leaving any residual conceptual
tissue that may jeopardize patency afterwards. As a part of report
on different conservative surgeries for tubal pregnancy, 3 cases of
segmental resection of tubal pregnancy and reanastomosis have
been reported with 2 successful pregnancies via laparotomy in the
[28]
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remaining fallopian tube for tubal pregnancy has been reported
with laparoscopy as a case report.[29] Salpingotomy and delayed
microsurgical reanastomosis as a secondary surgery for those
with conﬁrmed postoperative tubal obstruction have also been
described in several cases.[30] As such, reanastomosis following
segmental resection of the affected tubal portions have been
attempted, but the limitations in the ergonomics for laparoscopy
and the invasiveness of open microsurgical procedure have
limited its widespread application. As an alternative, salpingot-
omies have been performed more frequently, but the risk of
leaving the bleeding focus and residual trophoblastic tissue has
also limited its popularity. The pregnancy rates following
salpingotomy were between 60.7% and 67.0%, and signiﬁcant
residual trophoblastic tissue of 20% has been reported.
Conversion to salpingectomy was observed in up to 20% of
the cases and usually salpingotomy was successful only for small,
unruptured tubal pregnancies. Subsequent clean-up surgeries
were required in about 4% to 5% of the cases, due to incomplete
removal of conceptual tissue or rebleeding. Also recurrent tubal
pregnancy in the affected tube was observed in 3% to 12% of the
cases.[8–9] In this study, the ergonomics of the robotic surgery has
allowed reanastomosis of ruptured tubal pregnancies with a
median conceptus diameter of 3.47±1.33cm. Robotic guided
reanastomosis was possible for those with tubal rupture after
MTX administration, where conventionally salpingectomy
would have to be performed. Also, no subsequent residual
trophoblastic tissues leading to additional interventions nor
repeated tubal pregnancies have been observed up to a follow-up
period of 24 months.
Pregnancy rates at 12 to 48-month follow-up after reanasto-
mosis for tubal ligation lie in the range of 55% to 85% according
to previous reports with laparoscopy and 68% to 83% with
robotic surgery.[15–19,31] After tubal reanastomosis following
tubal pregnancy, the pregnancy rate was 63.6% at 24 months in
this series, compatible with previous reports in the literature
following tubal ligation. Lessons learned from previous reports
on tubal reanastomosis following sterilization were taken into
account for the surgical procedure. Thermal injury should be
minimized when resecting the ectopic mass, because the mode of
sterilization affects successful pregnancy outcome and residual
tubal length is positively correlated with success.[32,33] The range
of residual tubal length was 5.50 to 7.00cm in this study.
Shortening of the effective tubal length could be minimized by
resecting solely the portion of trophoblastic invasion while
preserving the remaining portion of the tube only affected by
bulging of the gestational sac or blood clot. These secondary
dilatations of the fallopian tubes were reversible, conﬁrmed by
postoperative HSG.
Unlike reanastomosis after tubal ligation, many of these
patients have underlying tubal dysfunction and preserving
patency would not ensure functional integrity. However, our
study indicates that a good proportion (63.64% at 24-month
follow-up) of those who have received reanastomosis conceived
naturally, where ARTwould have been required if salpingectomy
had been performed. Patients receiving tubal reanastomosis due
to ectopic pregnancy were generally young with a mean age of
28.88±4.75 years and generally had less motivation for
achieving immediate pregnancy, which may account for the
slightly lower pregnancy rate at 24 months. Additional
intrauterine pregnancies were observed at follow-ups beyond
24 months and with a longer follow-up period encompassing a
larger number of patients, cumulative pregnancy rates will7become more evident. Repeated tubal pregnancy was an
anticipated adversity, yet none had occurred during the 24
months follow-up period.
In comparison with reanastomosis after tubal ligation, certain
distinctive features need to be considered for the tubal
reanastomosis procedure following tubal pregnancy. The tubal
implant is highly vascularized and the morphology and
anatomical site of the lesion are less predictable. Thus, predicting
the success of reanastomosis for tubal pregnancy becomes more
difﬁcult compared with reanastomosis following tubal ligation,
showing a cancellation rate of 17.65% (3/17) in this analysis.
Also the length of tubal segment that needs to be resected is
usually longer and more distended, and thus greater degrees of
discrepancies between the proximal and distal ﬂaps are observed
for reanastomosis following ectopic pregnancy. Since ectopic
pregnancy is an implication of underlying tubal dysfunction,
patients receiving reanastomosis following tubal pregnancy may
have a lower pregnancy success rate despite successful intraop-
erative outcomes, and should be warned as such. Moreover, the
mean awaiting time from decision to surgery in this series was
28.31±19.11hours; however, having on demand access to
robotic surgery may not be available depending on the referral
system.
Some technical challenges may be encountered in the initial
cases, where being accommodated to the absence of tactile
sensations and relying only on visual guidance to estimate
tensile strength requires trial and error. This is a tedious task
when dealing with delicate tissue and suture materials. Having
the operator out of the operating ﬁeld with the robotic system is
also a disadvantage when handling ﬁne suture materials in and
out of the accessory port. For surgeons in training or those who
have not yet reached the learning curve for either robotic
surgery or tubal reanastomosis, intensive preclinical training
with animal models should be followed by supervised clinical
training.
The long-term outcomes and pregnancy rates of tubal
reanastomosis following segmental resection of tubal pregnancy
should be accumulated in future trials with larger number of
patients, and should be reproduced by different teams in the ﬁeld
of reproductive surgery. This study demonstrates that tubal
reanastomosis after segmental resection of tubal pregnancy using
the da Vinci system is a feasible means of salvaging fallopian tube
integrity and fertility in those with a single viable fallopian tube,
demonstrating natural pregnancy rates compatible with that of
conventional reanastomosis for tubal ligation.References
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